Ioanna Markaki

Karolinska Institutet

Sweden

Research Interests

Explore related searches

Professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (14)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (11)

Per Svenningsson

King’s College London

UNITED KINGDOM

View details

Michael Heneka

Full prof and Director

University of Bonn

GERMANY

View details

Mezin Öthman

Uppsala University

SWEDEN

View details

Caroline Ran

Karolinska Institutet

SWEDEN

View details

Per Odin

Lund University

SWEDEN

View details

Matthew Schrag

UNITED STATES

View details

Wojciech Paslawski

Assistant Professor

Karolinska Institutet

SWEDEN

View details

Maciej Machaczka

Karolinska Institutet

SWEDEN

View details

Danielle Taylor-te Vruchte

University of Oxford

UNITED KINGDOM

View details

Sofia Bergström

KTH Royal Institute of Technology

SWEDEN

View details

Dag Nyholm

Professor of Neurology

Uppsala University

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ioanna Markaki

Research Interests

Explore related searches

Contact this professor

Articles (14)

Levodopa–entacapone–carbidopa intestinal gel: Data from the Swedish national registry for Parkinson's disease

Vital nutrition: enhancing health in advanced Parkinson’s disease with device-aided therapies

High Cerebrospinal DOPA Decarboxylase Level Predicts Cognitive Decline in Parkinson's Disease

NLX‐112 Randomized Phase 2A Trial: Safety, Tolerability, Anti‐Dyskinetic, and Anti‐Parkinsonian Efficacy

Isolation of L1CAM‐Extracellular Vesicles Reveals Signs of Insulin Resistance in Parkinson's Disease

Reading Alterations in Parkinson's Disease Indicate Worse Cognitive Status

Glucocerebrosidase variant T369M is not a risk factor for Parkinson's disease in Sweden.

Glycosphingolipid Changes in Plasma in Parkinson's Disease Independent of Glucosylceramide Levels

A replication study, systematic review and meta-analysis of automated image-based diagnosis in parkinsonism

Mechanical thrombectomy in stroke patients of working age: Real-world outcomes in Sweden

Neurocognitive profile of adults with the Norrbottnian type of Gaucher disease

Novel targeted therapies for Parkinson’s disease

Reply to: “HbA1c and Motor Outcome in Parkinson's Disease in the Mark‐PD Study”

Multi‐cohort profiling reveals elevated CSF levels of brain‐enriched proteins in Alzheimer’s disease

Collaborators (11)

Per Svenningsson

Michael Heneka

Mezin Öthman

Caroline Ran

Per Odin

Matthew Schrag

Wojciech Paslawski

Maciej Machaczka

Danielle Taylor-te Vruchte

Sofia Bergström

Dag Nyholm

Make your next move.